Riskpilot← Back to searchSign inGet full accessSaraMed AB
ABActiveOrg 5592723737Kungsholms Hamnplan 5 ABeauty care and other beauty treatment activities · NACE 9622Est. 20200 employees
Revenue 2024
—
EBITDA margin
—
+20% vs 2023
Equity ratio
84.5%
Financial strength
Net profit 2024
SEK -6K
+19% vs 2023
| Revenue | — | — |
| EBITDA | SEK -6K | +20% |
| Net profit | SEK -6K | +19% |
| Total assets | SEK 34K | -17% |
| Equity | SEK 29K | -17% |
| Employees | 0 | — |
Legal name
SaraMed AB
Org number
5592723737
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
21 september 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall förvalta kapital knutet till medicinsk estetisk verksamhet och läkarkonsultverksamhet.
Address
Kungsholms Hamnplan 5 A
Email
saraelgharbi@live.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 126 | 43 | 0 | — |
| Staff expenses | — | −0 | — | — |
| EBITDA | 21 | 5 | −8 | −6 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 21 | 5 | −8 | −6 |
| Net financials | −3 | −1 | 0 | 0 |
| Profit before tax | 18 | 4 | −7 | −6 |
| Tax | −4 | −1 | — | — |
| Net profit | 14 | 3 | −7 | −6 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 104 | 58 | 42 | 34 |
| Equity | 39 | 42 | 35 | 29 |
| Long-term debt | 35 | 0 | — | — |
| Short-term debt | 30 | 16 | 7 | 5 |
| Total debt | 65 | 16 | 7 | 5 |
EBITDA margin
-605000.0%
This company
15.8%
Market median
-3829214% vs market
20212024
Equity ratio
84.5%
This company
38.2%
Market median
+121% vs market
20212024
Return on equity
-20.7%
This company
18.4%
Market median
-213% vs market
20212024
Net profit margin
-599700.0%
This company
8.1%
Market median
-7403804% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SaraMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Sara El Gharbi | Board of Directors | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Josefine Cecilia Maria Lind | Deputy Board Member | 0 companies |